Bone Biologics's total assets for Q2 2025 were $7.00M, an increase of 121.44% from the previous quarter. BBLG total liabilities were $406.14K for the fiscal quarter, a 61.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.